IRON
Disc Medicine Inc.
$86.22
+$0.47(+0.55%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$2.43B
Volume
252.82K
52W Range
$30.82 - $95.95
Target Price
$108.82
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | -- | $-600.0K | -- | -- | -- | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | $600.0K | -- | -- | -- | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $34.0M | $30.9M | $47.5M | $91.1M | $129.7M | ||
| Research & Development | $28.2M | $25.2M | $33.4M | $69.3M | $96.7M | ||
| Research Expense | $28.2M | $25.2M | $33.4M | $69.3M | $96.7M | ||
| Selling, General & Administrative | $5.9M | $5.8M | $14.0M | $21.9M | $33.0M | ||
| General & Administrative Expenses | $5.9M | $5.8M | $14.0M | $21.9M | $33.0M | ||
| Salaries & Wages | $-983.0K | $-507.0K | $-2.1M | $-5.5M | $-16.8M | ||
| Depreciation & Amortization | $300.0K | $-200.0K | -- | $100.0K | $200.0K | ||
| Depreciation & Amortization | $300.0K | $-200.0K | -- | $100.0K | $200.0K | ||
| Other Operating Expenses | -- | $-700.0K | $599.0K | $581.0K | $1.1M | ||
| OPERATING INCOME | |||||||
| Operating income | $-34.0M | $-30.9M | $-47.5M | $-91.1M | $-129.7M | ||
| EBITDA | $-33.7M | $-30.9M | $-47.4M | $-76.2M | $-108.8M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $6.8M | $2.2M | -- | -- | -- | ||
| Intinc | $37.0K | $14.0K | $709.0K | $14.8M | $21.3M | ||
| Net Non-Operating Interest Income/Expense | $-6.8M | $14.0K | $709.0K | $14.8M | $21.3M | ||
| Gain on Sale of Securities | -- | $-5.0M | $-61.0K | -- | -- | ||
| Other Income/Expense | $8.0K | $5.0M | $-61.0K | $2.0K | $2.0K | ||
| Other Special Charges | $-8.0K | $-724.0K | -- | $-2.0K | $-2.0K | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | $-1.4M | -- | -- | -- | ||
| Special Income Charges | -- | $1.4M | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-34.0M | $-30.9M | $-47.5M | $-76.3M | $-109.0M | ||
| Pre-Tax Income | $-40.8M | $-36.0M | $-46.8M | $-76.3M | $-109.0M | ||
| INCOME TAX | |||||||
| Tax Provision | -- | -- | -- | $99.0K | $355.0K | ||
| NET INCOME | |||||||
| Net Income | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
| Net Income (Continuing Operations) | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
| Net Income (Discontinued Operations) | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
| Net Income (Common Stockholders) | $-40.8M | $-36.0M | $-46.8M | $-76.4M | $-109.4M | ||
| Normalized Income | -- | -- | -- | -- | $-107.9M | ||
| TOTALS | |||||||
| Total Expenses | $34.0M | $30.9M | $47.5M | $91.1M | $129.7M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $15.1M | $4.0M | $1.0M | $22.3M | $27.6M | ||
| Average Shares Outstanding (Diluted) | $15.1M | $4.0M | $1.0M | $22.3M | $27.6M | ||
| Shares Outstanding | $4.3M | $4.3M | $19.0M | $24.7M | $34.6M | ||
| Basic EPS | $-2.7 | -- | $-45.05 | $-3.42 | $-3.96 | ||
| Basic EPS (Continuing Operations) | $-2.7 | -- | $-45.05 | $-3.42 | $-3.96 | ||
| Diluted EPS | $-2.7 | $-17.8 | $-45.05 | $-3.42 | $-3.96 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-45.05 | $-3.42 | $-3.96 | ||
| OTHER METRICS | |||||||
| Accrued Preferred Stock Dividends | -- | $36.0M | $46.8M | $76.4M | -- | ||
| Gain On Sale Of P P E | -- | $300.0K | -- | -- | -- | ||
| Other Gand A | $5.9M | $5.8M | $14.0M | $21.9M | $33.0M | ||
| Otherunder Preferred Stock Dividend | -- | $36.0M | $46.8M | $76.4M | -- | ||
| Preferred Stock Dividends | -- | $36.0M | $46.8M | $76.4M | -- | ||
| Rent And Landing Fees | $1.0M | $20.3M | -- | -- | -- | ||
| Restruct | -- | $-1.4M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRON | $86.22 | +0.5% | 252.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |